Target Name: KLHDC7A
NCBI ID: G127707
Review Report on KLHDC7A Target / Biomarker Content of Review Report on KLHDC7A Target / Biomarker
KLHDC7A
Other Name(s): Kelch domain containing 7A | KLD7A_HUMAN | kelch domain containing 7A | Kelch domain-containing protein 7A | RP11-422P22.2 | kelch domain-containing protein 7A

KLHDC7A: A Protein Interaction and Cell Signaling Lactant

The Kelch domain containing 7A (KLHDC7A) protein is a protein that is expressed in various tissues of the human body. It is a member of the Kelch domain family, which is a type of cytoplasmic protein that plays a variety of roles in cellular signaling and regulation. One of the unique features of KLHDC7A is its ability to interact with other proteins and molecules, which has led to its potential as a drug target or biomarker.

The Kelch domain is a small protein domain that is located at the N-terminus of various cytoplasmic proteins. It is characterized by a unique arrangement of amino acids that gives it its unique structure and function. The Kelch domain is involved in several cellular processes, including cell signaling, cytoskeletal organization, and protein-protein interactions.

KLHDC7A is a 21-kDa protein that is expressed in various tissues of the human body, including muscle, heart, liver, and brain. It is primarily localized to the cytoplasm of cells, where it can interact with other proteins and molecules. The protein is composed of 115 amino acids, with its highest concentration in the cytoplasm.

One of the unique features of KLHDC7A is its ability to interact with the protein p120GAP. This interaction between the two proteins is thought to play a role in the regulation of cellular processes such as cell signaling and cytoskeletal organization.

In addition to its interaction with p120GAP, KLHDC7A has also been shown to interact with several other proteins, including the transcription factor p53 and the protein kinase ALCAT3. These interactions may have important implications for the regulation of cellular processes and the development of diseases.

KLHDC7A has also been shown to play a role in the regulation of cellular signaling pathways. For example, it has been shown to interact with the protein PDGF-尾, which is a key regulator of cell signaling. This interaction between the two proteins may be important for the regulation of cellular processes such as cell proliferation and survival.

In addition to its role in cellular signaling, KLHDC7A has also been shown to play a role in the regulation of cytoskeletal organization. It is a member of the Kelch domain family, which is involved in the regulation of cytoskeletal organization and dynamics. This may be important for the regulation of cellular processes such as cell migration and the formation of tissues.

KLHDC7A has also been shown to play a role in the regulation of protein-protein interactions. It is a member of the Kelch domain family, which is involved in protein-protein interactions. This may be important for the regulation of cellular processes such as protein-protein interactions and the regulation of cellular signaling pathways.

In conclusion, the Kelch domain containing 7A (KLHDC7A) protein is a unique protein that is expressed in various tissues of the human body. It is characterized by its ability to interact with other proteins and molecules, which has led to its potential as a drug target or biomarker. The protein has also been shown to play a role in several cellular processes, including cell signaling, cytoskeletal organization, and protein-protein interactions. Further research is needed to fully understand the functions of KLHDC7A and its potential as a drug target or biomarker.

Protein Name: Kelch Domain Containing 7A

The "KLHDC7A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLHDC7A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KLHDC7B | KLHDC7B-DT | KLHDC8A | KLHDC8B | KLHDC9 | KLHL1 | KLHL10 | KLHL11 | KLHL12 | KLHL13 | KLHL14 | KLHL15 | KLHL17 | KLHL18 | KLHL2 | KLHL20 | KLHL21 | KLHL22 | KLHL23 | KLHL24 | KLHL25 | KLHL26 | KLHL28 | KLHL29 | KLHL3 | KLHL30 | KLHL30-AS1 | KLHL31 | KLHL32 | KLHL33 | KLHL34 | KLHL35 | KLHL36 | KLHL38 | KLHL4 | KLHL40 | KLHL41 | KLHL42 | KLHL5 | KLHL6 | KLHL7 | KLHL7-DT | KLHL8 | KLHL9 | KLK1 | KLK10 | KLK11 | KLK12 | KLK13 | KLK14 | KLK15 | KLK2 | KLK3 | KLK4 | KLK5 | KLK6 | KLK7 | KLK8 | KLK9 | KLKB1 | KLKP1 | KLLN | KLRA1P | KLRB1 | KLRC1 | KLRC2 | KLRC3 | KLRC4 | KLRC4-KLRK1 | KLRD1 | KLRF1 | KLRF2 | KLRG1 | KLRG2 | KLRK1 | KLRK1-AS1 | KMO | KMT2A | KMT2B | KMT2C | KMT2CP4 | KMT2D | KMT2E | KMT2E-AS1 | KMT5A | KMT5B | KMT5C | KNCN | KNDC1 | KNG1 | KNL1 | KNOP1 | KNOP1P5 | KNSTRN | KNTC1 | KPNA1 | KPNA2 | KPNA3 | KPNA4 | KPNA5